Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth.
about
IRAK signalling in cancerToll-like receptors in systemic lupus erythematosus: potential targets for therapeutic interventionSystems genetics of metabolism: the use of the BXD murine reference panel for multiscalar integration of traitsMolecular and cellular mechanisms responsible for cellular stress and low-grade inflammation induced by a super-low dose of endotoxinRole of IRAK-M in alcohol induced liver injury.TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth.Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancerThe involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammationAltered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice.The interleukin-1 receptor-associated kinase M selectively inhibits the alternative, instead of the classical NFkappaB pathway.Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M.Targeting Toll-like receptors for treatment of SLEIRAK-M regulation and function in host defense and immune homeostasis.The structure function of the death domain of human IRAK-M.Ganglioside-exposed dendritic cells inhibit T-cell effector function by promoting regulatory cell activity.Programming and memory dynamics of innate leukocytes during tissue homeostasis and inflammation.Mechanical ventilation modulates TLR4 and IRAK-3 in a non-infectious, ventilator-induced lung injury model.Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance.IL-1 receptor-associated kinase M downregulates DSS-induced colitis.Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers.
P2860
Q26863735-B58330E2-A1B5-454E-9131-94585D2EFFF0Q26865485-452D8A51-283F-420D-8EF1-785C08384B90Q30485668-CF29F2A1-B720-4FF2-A058-A1BA70106C16Q33718511-D286E2B4-A742-420C-88BD-48709542DFE0Q34600023-0F8B0CB6-990F-46EB-AB2F-E59AEC1F1424Q35009619-BFC1E358-3F30-40C3-AFCB-1E1D9ED0A43AQ36584002-A02F4550-48FE-49B3-B8A0-161EDC30F29AQ37076790-39C04B37-ED15-4772-A121-570A7CA653EEQ37097054-26392BF2-E707-407E-9BE7-26BF163844CEQ37374200-BB1B7033-F729-4B46-9EA2-1890D4A6F943Q37584293-D869AB68-1EA7-4372-B3B4-917D5A17864BQ37795596-1634E313-180D-45D2-8C73-61A69231DFADQ37851354-253EB6E4-F75B-40DD-BF86-437948D77E31Q38931685-DCE6CD33-9F46-415D-8265-55D75A6150D1Q39099975-11E28A71-D921-4895-93F4-356F62CF67B9Q39286818-872AE20C-CA3A-43D9-A174-8764B013A3C7Q39686934-9D587550-2073-468F-B4F7-A53A3370FF1FQ39726876-C95A296A-EBAC-4803-94D5-F1DABC8DA8B9Q39836785-84B7E6A5-0DE2-40E1-8604-BF3D47BA5461Q51065862-A1C7603D-C625-49EE-B2AE-71FB427BC851
P2860
Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Loss of the innate immunity ne ...... defense against tumor growth.
@en
type
label
Loss of the innate immunity ne ...... defense against tumor growth.
@en
prefLabel
Loss of the innate immunity ne ...... defense against tumor growth.
@en
P2093
P2860
P1433
P1476
Loss of the innate immunity ne ...... defense against tumor growth.
@en
P2093
Ingred Wilson
Jianxia Wang
P2860
P304
P356
10.1016/J.MOLIMM.2007.03.018
P50
P577
2007-05-02T00:00:00Z